ArticleCureus2024
Clinicopathological Characteristics of Thyroid Cancer: A 10-Year Experience at a Tertiary Care Center in Saudi Arabia.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Thyroid nodules are typically an initial sign of thyroid cancer (TC) and require evaluation by thyroid ultrasonography. Additional measures, such as fine needle aspiration, may be necessary depending on the level of malignancy risk. This study aims to comprehensively analyze TC clinical, radiological, and histopathological characteristics in a cohort of Saudi patients. Methods A retrospective chart review was carried out on TC patients who were being followed up at a tertiary care center in the Riyadh region of Saudi Arabia. The study included all patients aged 15 years and above diagnosed between 2013 and 2022 with adequate histopathological data. Statistical analysis used: SPSS v.27 was used for the data analysis. Results In total, 272 patients were included in the study, with a mean age of 47.23 ± 12.6 years. Of these, 222 (81.6%) were females. Nearly two-thirds of the affected patients had a body mass index (BMI) exceeding 25. The most common histological type of cancer was classical papillary thyroid carcinoma, accounting for 58.5% of cases. The average tumor size was 2.52 cm. The majority of patients presented with TNM stage I (86%), while one-fourth of the study population had thyroid imaging reporting and data systems (TI-RADS) 6 and Bethesda V. metastatic lymph nodes were predominantly among males (57.8%), and those younger than 50 years of age. The extrathyroidal extension was observed in 72% of tall-cell papillary thyroid carcinomas and 62.5% of oncocytic variant papillary thyroid carcinomas, compared to less than 50% in other subtypes (p < 0.001). Conclusions In our study, TC primarily affects obese middle-aged women. However, male gender and younger age are significant risk factors for lymph node involvement. Additionally, histopathological subtypes, rather than clinical parameters, are more likely to increase the risk of extrathyroidal extension. Given the conflicting data regarding clinical risk factors associated with the development of TC, lymph node metastasis, and extrathyroidal extension, further research is needed to clarify these discrepancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.